Cynapsus Therapeutic (CYNAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CYNAF | PYXS | VRCA | ||
| Company | Cynapsus Therapeutic | Pyxis Oncology Inc | Verrica Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 0.9984 | 1.7000 | 5.89 | ||
| High | 0.9984 | 1.7800 | 6.38 | ||
| Low | 0.9600 | 1.6600 | 5.86 | ||
| Latest | 0.9600 | 1.7100 | 6.15 | ||
| Change | -0.0330 | +0.0100 | +0.28 | ||
| % Change | -3.32% | +0.59% | +4.77% | ||
| Volume | 31,200 | 284,000 | 43,000 | ||
| 20-Day Average Volume | N/A | 661,110 | 59,820 | ||
| Previous Close | 0.9930 | 1.7000 | 5.87 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | N/A | 2.0570 | 6.42 | ||
| 20-Day Raw Stochastic | N/A | 10.26% | 23.43% | ||
| 20-Day Relative Strength | N/A | 45.66 | 48.93 | ||
| Weighted Alpha | N/A | +9.99 | -54.43 | ||
| Today's Opinion | N/A | 40% Sell | 8% Sell | ||
| Previous Opinion | N/A | 40% Sell | 24% Sell | ||
| Last Month's Opinion | N/A | 8% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.32% since 04/18/16 | -3.93% since 05/28/26 | +1.91% since 05/28/26 | ||
| Low | 0.9600 on 05/09/16 | 1.6600 on 06/04/26 | 5.62 on 06/03/26 | ||
| High | 0.9984 on 05/09/16 | 1.8799 on 05/29/26 | 6.38 on 06/04/26 | ||
| 1-Month | |||||
| %Chg | -9.18% since 02/24/14 | -2.84% since 05/04/26 | -3.30% since 05/04/26 | ||
| Low | 0.9494 on 04/18/16 | 1.5717 on 05/26/26 | 5.48 on 05/22/26 | ||
| High | 1.0872 on 04/18/16 | 2.9200 on 05/11/26 | 8.50 on 05/06/26 | ||
| 3-Month | |||||
| %Chg | N/A since 02/24/14 | +14.77% since 03/04/26 | +15.38% since 03/04/26 | ||
| Low | 0.9494 on 04/18/16 | 1.2600 on 03/30/26 | 4.24 on 03/24/26 | ||
| High | 1.0872 on 04/18/16 | 2.9200 on 05/11/26 | 8.50 on 05/06/26 | ||
| 6-Month | |||||
| %Chg | N/A since 02/24/14 | -60.42% since 12/04/25 | -26.96% since 12/04/25 | ||
| Low | 0.9494 on 04/18/16 | 1.0300 on 12/26/25 | 4.24 on 03/24/26 | ||
| High | 1.0872 on 04/18/16 | 4.5800 on 12/12/25 | 9.78 on 12/05/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 107,680 | 107,703 | 100,841 | ||
| Shares Outstanding, K | 110,310 | 63,355 | 17,179 | ||
| Annual Sales | 0 | 13,860,000 | 35,580,000 | ||
| Annual Net Income | 9,800,000 | -79,620,000 | -17,890,000 | ||
| Last Quarter Sales | 0 | 11,040,000 | 5,020,000 | ||
| Last Quarter Net Income | -4,220,000 | -18,110,000 | -9,680,000 | ||
| 60-Month Beta | 1.71 | 1.42 | 1.49 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.37 on 05/14/26 | -0.41 on 05/12/26 | ||
| Earnings Date | 08/12/15 | 08/13/26 | 08/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||